Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke

Official title: Effect of Ideomotor Apraxia on the Outcomes of Robotic Gait Rehabilitation in Patients With Stroke: A Prospective Observational Study

Run by Izmir City Hospital · NCT07881471 · Data updated 2026-11-12

This study tests whether ideomotor apraxia affects improvements in walking, balance, and independence during rehabilitation after stroke, using conventional therapy plus RehaWalk at Izmir City Hospital.

More Stroke trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment60 (estimated)
SponsorIzmir City Hospital
Government
Locations1 site (Izmir, İzmir)
StatusRecruiting
StartedOctober 30, 2026
Main results expectedSeptember 30, 2027
Study endsOctober 30, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07881471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with ischemic or hemorrhagic stroke, scheduled for robotic gait rehabilitation, at least 1 month since stroke onset, able to walk 10 meters with or without aid, and able to comply with TULIA assessment.

Probably not a fit

Patients who do not have ideomotor apraxia or who cannot participate in robotic gait rehabilitation may not experience study-derived insights.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational cohort study at Izmir City Hospital. It will classify participants by ideomotor apraxia status using the Test of Upper Limb Apraxia (TULIA) before rehabilitation. All participants receive routine rehabilitation plus RehaWalk-supported gait training (three sessions per week for up to five weeks) and will be assessed at baseline and after the 15th session or at discharge. The main goal is to determine whether baseline apraxia is independently associated with functional gains measured during standard care; outcome assessors will be blinded to apraxia status. No experimental treatments are administered; the study observes routine care to understand prognostic relationships.

Why it matters

Potential benefit: If successful, the findings could help clinicians tailor rehabilitation expectations and planning for patients with ideomotor apraxia after stroke.

How similar studies have gone: Previous studies have explored apraxia and motor recovery in stroke, but this observational approach focusing on prognostic association with robotic gait rehabilitation is comparatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years or older.
2. Clinically and radiologically confirmed ischemic or hemorrhagic stroke.
3. Scheduled to receive robotic gait rehabilitation as part of routine clinical care.
4. At least 1 month since stroke onset.
5. Ability to walk at least 10 meters with or without an assistive device.
6. Ability to stand independently or under supervision for at least 2 minutes.
7. Brunnstrom lower extremity recovery stage of 3 or higher.
8. Modified Ashworth Scale score below 3 for the plantar flexor muscle group.
9. Sufficient upper extremity motor function to permit TULIA assessment, defined as a Fugl-Meyer Assessment upper extremity motor score of at least 20.
10. Sufficient cognitive ability to understand the study assessments, defined as a Mini-Mental State Examination score of at least 18.
11. Ability to understand the informed consent form and provide written informed consent.

Exclusion Criteria:

1. Failure to provide written informed consent or withdrawal of consent.
2. Severe aphasia or advanced cognitive impairment preventing understanding or completion of the study assessments.
3. Severe unilateral neglect.
4. Cerebellar stroke.
5. Parkinson's disease, multiple sclerosis, motor neuron disease, or another neurological disorder that may affect walking.
6. Orthopedic disease or previous surgery substantially affecting lower extremity function, including advanced osteoarthritis, lower extremity amputation, unhealed fracture, or severe contracture.
7. Severe plantar flexor spasticity, defined as a Modified Ashworth Scale score of 3 or higher.
8. Cardiovascular or systemic disease preventing safe participation in robotic gait rehabilitation, including unstable angina, uncontrolled arrhythmia, decompensated heart failure, uncontrolled hypertension, acute infection, or severe respiratory failure.
9. Conditions preventing safe use of the gait rehabilitation system, including inability to use the safety belt or suspension system appropriately, severe lower extremity deformity, serious skin lesions or pressure ulcers, or height or body weight outside the manufacturer's specified limits.
10. Severe visual or hearing impairment preventing reliable administration of the assessments.
11. Any condition judged by the investigator to make participation unsafe or prevent compliance with the study protocol.

Where it's running

  • Izmir City Hospital
    Izmir, İzmir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.